MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...

“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...

Hologic HOLX, a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, ...

Marlborough medical device manufacturer Hologic, Inc., announced Tuesday the launch of a new device designed to address abnormal uterine bleeding. The NovaSure V5 global endometrial ablation device ...

Hologic has made progress in mitigating the tariff impact ... Despite declining domestic sales, NovaSure has consistently delivered double-digit growth overseas, highlighting the vast potential to ...

Hologic (HOLX) has strengthened its GYN surgical segment with the acquisition of privately-held Massachusetts-based Interlace Medical for $125 million in cash and two annual contingent payments, ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Court of Appeals for the Federal Circuit unanimously affirmed a 2021 district court ruling that ...

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...